NCT04586660 2025-10-01
Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone
Amgen
Phase 4 Active not recruiting
Clinical Trials
5 trialsNCT03301857 2024-05-20
Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004
Amgen
Phase 4 Completed
NCT05813665 2023-04-19
A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone
Shanghai JMT-Bio Inc.
Phase 3 Not yet recruiting
NCT04255576 2022-10-14
Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone
Shanghai JMT-Bio Inc.
Phase 1/2 Unknown
NCT05402865 2022-06-02
A Real-world Study on Patients of Unresectable Giant Cell Tumor of Bone
Shanghai JMT-Bio Inc.
Completed